Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2017Annals of Internal Medicine

CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration

View Full Paper
Ask AI
Bookmark
Share

Authors

CCChung Wah ChengTWTaixiang WuHSHongcai Shang

Discussion

Loading...

Member takes

Overview

Consensus guideline reports improved reporting standards in Chinese herbal medicine clinical trials, highlighting enhanced transparency and study reproducibility.

Key Points

  • To develop an extension of the CONSORT 2010 Statement tailored to the specific characteristics of Chinese herbal medicine formulas to improve trial reporting quality.
  • Convened an expert panel comprising traditional Chinese medicine clinicians, methodologists, epidemiologists, and journal editors.
  • Developed recommendations through an iterative consensus process involving drafting, public solicitation of feedback, revision, and finalization.
  • Extended the CONSORT 2010 framework by incorporating traditional Chinese medicine patterns, formula characteristics, and an additional checklist subitem for indexing keywords.
  • Elaborated seven existing checklist items—including title and abstract, background, participants, interventions, outcomes, generalizability, and interpretation—and updated reporting standards for harms.

Cite This Study

Cheng et al. (2017) studied this question.

synapsesocial.com/papers/6a7d760a97c2c6e4659665f0https://doi.org/10.7326/m16-2977
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<italic>SPIRIT Extension for Chinese Herbal Medicine Formula 2025</italic>: Recommendations, explanation, and elaboration2026 · 1 citations
  2. 2Inadequate Reporting of Harms in RCTs of Chinese Herbal Medicine Formulas: A Systematic Survey of Leading Medical Journals2026
  3. 3Traditional Chinese medicine: extension guidelines for international clinical research reporting standards.2026
  4. 4Placebo design, reporting compliance, and methodological problems in randomized, placebo-controlled trials of Chinese herbal medicine: A cross-sectional study2026
  5. 5Design, Conduct, and Analysis of Randomized Clinical Trials of Chinese Herbal Medicine2026